Mechanisms of Anesthesia Mediated Neurotoxicity
Mechanisms of Anesthesia Mediated Neurotoxicity
批准号:
9022481
负责人:
HUAFENG WEI
金额:
$32.35万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-22 至 2018-12-31
关键词:
AffectAgeAnesthesia proceduresAnestheticsAnimalsApoptosisApoptosis InhibitorAttentionAutophagocytosisBCL2 geneBrainBrain regionCalciumCalcium ChannelCalcium SignalingCell Culture TechniquesCell DeathCell SurvivalCell physiologyCerebral IschemiaCognitionDLG4 geneDataDoseEndoplasmic ReticulumEventExcitatory SynapseFRAP1 geneGeneral anesthetic drugsGoalsHealthHippocampus (Brain)Impaired cognitionImpairmentInhibitory SynapseInositolInterventionIsofluraneLearningLithiumLong-Term EffectsLong-Term PotentiationMeasurementMeasuresMediatingMembraneMemoryMitochondriaModelingMolecularMusMyocardial IschemiaNeuronsNuclearPatch-Clamp TechniquesPathway interactionsPropofolRegulationRoleSirolimusSiteSliceStagingSynapsesSynapsinsSynaptic TransmissionTestingTimeWestern Blottingcell injurycognitive functiondesfluranegephyrininhibitor/antagonistmorris water mazeneuron apoptosisneuronal survivalneuroprotectionneurotoxicneurotoxicitynovelobject recognitionpatch clamppatient safetypostsynapticpresynapticreceptorreticulum cellsevofluranesynaptic functiontripolyphosphate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our recent preliminary studies suggest that the commonly used general anesthetics (GAs), isoflurane and propofol, regulate autophagy via mTOR dependent pathway by activation of InsP3R Ca channel 2+ opening, which contribute to GAs effect on cell survival or death. The overarching goal of this R01 renewal is to investigate the mechanisms of GAs on autophagy activity via activation of InsP3Rs and the subsequent role on cell survival or death, synapse integrity and function and cognitive function. Thus, we hypothesize that GAs modulate autophagy through a dose- and time-dependent activation of InsP3 R, and the magnitude determines the fate of neuronal survival, synaptic integrity and function, and subsequent cognitive function. We have set up three specific aims (SA) to investigate this hypothesis: SA1). We will determine the role of GA-mediated activation of InsP3R subtypes on modulation of autophagy. Using the single channel nuclear patch-clamp technique in cell cultures with various levels of each subtype of InsP3R, we will characterize and compare the activating potency of four GAs (propofol, isoflurane, sevoflurane and desflurane) on each of the three subtypes of InsP3Rs, and correlate patch-clamp data with anesthetics-evoked changes in cytosolic, mitochondrial and ER Ca2+ concentrations. We will study the effects and mechanisms of GAs on autophagy via mTOR dependent pathway using various stimulators and inhibitors and controls of various autophagy regulatory sites in different cell cultures or hippocampus or cortex with different levels of baseline autophagy and InsP3R activity. SA2). We will determine the role of GA-modulated autophagy on apoptosis and synaptic integrity. We will study the effects of GAs on autophagy and apoptosis simultaneously in the same cell cultures and brain regions of mice with varying levels of autophagy and InsP3R baseline activity, in the presence or absence of various autophagy and apoptosis stimulators or inhibitors. We will study the GAs effects on synapse integrity by measuring changes of presynaptic synapsins and postsynaptic markers in primary neuronal cultures or hippocampus and cortex of mice with deficient autophagy or InsP3R-1. SA3). We will determine the role of GA-modulated autophagy on synaptic and cognitive function. We will study the long-term effects of GAs on basic synaptic transmission, long term potentiation (LTP) in hippocampal slices, and cognition in mice with deficient autophagy or InsP3R-1, in the presence or absence of various autophagy and apoptosis stimulators and inhibitors. We will correlate these GAs effects on synapse and cognitive function to their effects on activation of InsP3R, Ca release from the 2+ ER, autophagy activity and related apoptosis and synapse integrity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
-
批准号:10343664
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
-
批准号:10570995
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
-
批准号:10227272
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2019
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:7929736
-
项目类别:
-
资助金额:$14.78万
-
财政年份:2009
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:7690355
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:7504657
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:8306165
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:8113131
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:8264392
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:7893633
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:7057847
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:6859612
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:7596179
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:7386006
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:7215168
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: